Home Lifestyle Hollywood Box Office: ‘Morbius’ takes $39-M Domestically, $84-M Globally

Box Office: ‘Morbius’ takes $39-M Domestically, $84-M Globally

#BoxOffice #Morbius #vampire


Jared Leto’s new movie Morbius took in $39.1-M from 4,268 theaters in its domestic box office debut, in line with expectations after lukewarm reviews. Globally, it took in $84-M.

The movie is Sony’s latest attempt to mine the comic book characters it controls as part of Marvel‘s Spider-Man universe following the smash success of its Spider-Man and Venom movies.

Insiders stress that Morbius is not a traditional superhero offering, but a dark, genre thriller revolving around a vampire.

Morbius cost a reported $75-M to make before marketing, far less than a marquee superhero offering such as Spider-Man: No Way Home, and also less than Venom. Males fueled the film (60%), while nearly 70% of ticket buyers were between ages 18-34.

Morbius holds just a 17% rating on Rotten Tomatoes from critics. Audiences are also mixed, giving it a C+ CinemaScore, while exit scores on PostTrak are likewise mediocre. The audience score on Rotten Tomatoes is 67%.

Morbius won the weekend, both domestically and internationally. So far, there is no talk of a sequel.

Paramount’s The Lost City, starring Sandra Bullock and Channing Tatum, came in #2 domestically in its second frame with $14.8-M for a North American haul of $54.6-M. It has only rolled out in 17 markets so far overseas for an early foreign total of $7-M and $61.6-M worldwide.

The big player for Paramount overseas was Sonic the Hedgehog 2, which is rolling out in select markets ahead of its 8 April domestic launch. Sonic 2 opened to to $25.5-M in ticket sales from 31 markets.

Have some fun, see a movie in a theater, the chaos is over, Keep the Faith!

Previous articleTravel: Trans Siberian Railway through Russia, Mongolia and China
Next articleCommentary: Paul Ebeling on Wall Street and Beyond
Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he is the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.